Email Updates

You are here

Home»Resources

Webinar & Meeting Reports

  • Tales from Two Cities: HIV and STI research highlights from Brisbane and Chicago

    August 3, 2023

    The Choice Agenda (TCA) invited experts will share their highlights and reflections on the HIV and STI-related science presented at two major global health conferences. These conferences include IAS 2023, taking place in Brisbane, Australia July 23 – 26 and the 2023 STI and HIV World Congress happening in Chicago (United States) from July 24 – July 27.

  • ISSTDR (International Society for Sexually Transmitted Diseases Research) 2023

    July 24, 2023 to July 27, 2023

    The 25th ISSTDR (International Society for Sexually Transmitted Diseases Research) meeting will be held as a joint meeting with the 24nd IUSTI World meeting in Chicago, Illinois (US) from July 24 to July 27. Full schedule and registration details here.

  • IAS (International AIDS Society) 2023

    July 23, 2023 to July 27, 2023

    The 12th IAS (International AIDS Society) Conference on HIV Science, will take place in Brisbane, Australia, and virtually from July 23 to 26. IAS 2023, being held at the Brisbane Convention and Exhibition Centre, will shine a spotlight on the world’s advances in HIV research.

  • Women Deliver 2023

    July 17, 2023 to July 20, 2023

    The Women Deliver 2023 Conference (WD2023) will take place in Kigali, Rwanda  and online from July 17 to July 20. Women Deliver convenings catalyze conversations with stakeholders from around the world, break barriers, address challenges, and identify opportunities to advance gender equality and sexual and reproductive health and rights (SRHR), and improve the wellbeing of girls and women, in all their intersecting identities.

  • PrEP That Booty: The latest on rectal microbicide research for the back door

    June 29, 2023

    Thursday, June 29 at 9:00 AM–10:30AM ET
    Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver. However, these attributes are not desirable to many folks, and communities want a range of choices.

  • SA AIDS Conference

    June 20, 2023 to June 23, 2023

    The 11th SAAIDS Conference 2023, under the Theme: Act, Connect and End the Epidemic will be at the Durban ICC on the 20th -23rd June, 2023. Now, more than ever before, we need to ACT to end an epidemic that has been a part of our lives for decades. We hope to do this by bringing the HIV community together under the same roof, post the COVID-19 pandemic restrictions, to deliberate on next steps towards an AIDS free generation in 2030.

  • To bNAb or Not to bNAb? The case for broadly neutralizing antibodies

    June 7, 2023

    Join AVAC and partners for a conversation to explore the potential role of bNAbs in prevention, our current status in the field, and key issues to consider in HIV vaccine research.

  • SCOPE Community E-meeting: Developments in PrEP implementation issues

    June 7, 2023

    The European AIDS Treatment Group, along with European and local organizations are coming together for a virtual meeting via Zoom e-meeting on Wednesday, June 7 at 6:00 to 7:30 AM ET (12:00 – 13:30 PM CET).

  • What’s All the Buzz About: mRNA, manufacturing, vaccine access

    June 1, 2023

    Local production has emerged as an essential part of the solution for ensuring sustainable and equitable supplies of vaccines in low- and middle-income countries. This webinar will explore how might local manufacturing and the new mRNA Hub in South Africa facilitate access and support R&D.

  • Advancing HIV Cure to Africa: What is needed?

    May 25, 2023

    Thursday, May 25 at 15:30 to 17:30 CET (16:30 to 18:30 EAT; 13:30 to 15:30 GMT; 9:30 to 11:30 EDT)
    The HIV epidemic continues to have a tremendous impact on global health. While we have made enormous progress in making antiretroviral therapy available to many people living with HIV, we are still not capable of eliminating infection. Consequently, people with HIV must commit to expensive, lifelong therapies; continuous monitoring; and they face drug toxicities and chronic immune activation. There is thus an urgent need to develop safe, affordable, and globally accessible curative strategies. While HIV cure research slowly becomes more mainstream in high income countries, Africa runs the risk of being left behind.

Pages